Search for other papers by David Koeckerling in
Google Scholar
PubMed
Search for other papers by Jeremy W Tomlinson in
Google Scholar
PubMed
Search for other papers by Jeremy F Cobbold in
Google Scholar
PubMed
NAFLD, although the evidence supporting these adverse events is disputed ( 21 , 62 ). Dipeptidyl peptidase-4 (DPP-4) inhibitors increase incretin availability and are widely employed as adjunctive oral therapy in T2DM ( 21 ). DPP-4 inhibitors have
Faculté de Médecine Lyon Est, Université Lyon 1, Lyon, France
INSERM U1052; CNRS UMR5286; Cancer Research Centre of Lyon, Lyon, France
Search for other papers by Hélène Lasolle in
Google Scholar
PubMed
UFR Sciences médicales, Université de Bordeaux, Bordeaux, France
Search for other papers by Amandine Ferriere in
Google Scholar
PubMed
INSERM U1052; CNRS UMR5286; Cancer Research Centre of Lyon, Lyon, France
Centre de Pathologie et de Neuropathologie Est, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France
Search for other papers by Alexandre Vasiljevic in
Google Scholar
PubMed
Service d’anatomo-pathologie, Hopital Pellegrin, CHU de Bordeaux, Bordeaux, France
Search for other papers by Sandrine Eimer in
Google Scholar
PubMed
Search for other papers by Marie-Laure Nunes in
Google Scholar
PubMed
UFR Sciences médicales, Université de Bordeaux, Bordeaux, France
Search for other papers by Antoine Tabarin in
Google Scholar
PubMed
disease ( 12 ). As was noted in previous trials ( 9 , 10 , 11 , 12 , 17 ), impaired glycemic tolerance resulting from inhibition of insulin and incretin secretion ( 18 ), was the main drawback of Pasireotide-LAR treatment. The proportion of diabetic
Cooperative Research Centre for Cell Therapy Manufacturing (CRC-CTM), Adelaide, South Australia, Australia
Department of Medicine, Faculty of Health and Medical Sciences, University of Adelaide, South Australia, Australia
Search for other papers by Darling M Rojas-Canales in
Google Scholar
PubMed
St Vincent’s Institute of Medical Research, Fitzroy, Victoria, Australia
The University of Melbourne, Department of Medicine, St. Vincent’s Hospital, Fitzroy, Victoria, Australia
Search for other papers by Michaela Waibel in
Google Scholar
PubMed
Search for other papers by Aurelien Forget in
Google Scholar
PubMed
Cooperative Research Centre for Cell Therapy Manufacturing (CRC-CTM), Adelaide, South Australia, Australia
Department of Medicine, Faculty of Health and Medical Sciences, University of Adelaide, South Australia, Australia
Search for other papers by Daniella Penko in
Google Scholar
PubMed
Cooperative Research Centre for Cell Therapy Manufacturing (CRC-CTM), Adelaide, South Australia, Australia
Department of Medicine, Faculty of Health and Medical Sciences, University of Adelaide, South Australia, Australia
Search for other papers by Jodie Nitschke in
Google Scholar
PubMed
Future Industries Institute, University of South Australia, Mawson Lakes, South Australia, Australia
Search for other papers by Fran J Harding in
Google Scholar
PubMed
Future Industries Institute, University of South Australia, Mawson Lakes, South Australia, Australia
Search for other papers by Bahman Delalat in
Google Scholar
PubMed
Future Industries Institute, University of South Australia, Mawson Lakes, South Australia, Australia
School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia, Australia
Search for other papers by Anton Blencowe in
Google Scholar
PubMed
St Vincent’s Institute of Medical Research, Fitzroy, Victoria, Australia
Search for other papers by Thomas Loudovaris in
Google Scholar
PubMed
Transplantation Immunology Group, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia
Search for other papers by Shane T Grey in
Google Scholar
PubMed
St Vincent’s Institute of Medical Research, Fitzroy, Victoria, Australia
The University of Melbourne, Department of Medicine, St. Vincent’s Hospital, Fitzroy, Victoria, Australia
Search for other papers by Helen E Thomas in
Google Scholar
PubMed
St Vincent’s Institute of Medical Research, Fitzroy, Victoria, Australia
The University of Melbourne, Department of Medicine, St. Vincent’s Hospital, Fitzroy, Victoria, Australia
Search for other papers by Thomas W H Kay in
Google Scholar
PubMed
Cooperative Research Centre for Cell Therapy Manufacturing (CRC-CTM), Adelaide, South Australia, Australia
Department of Medicine, Faculty of Health and Medical Sciences, University of Adelaide, South Australia, Australia
Search for other papers by Chris J Drogemuller in
Google Scholar
PubMed
Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia
Search for other papers by Nicolas H Voelcker in
Google Scholar
PubMed
Cooperative Research Centre for Cell Therapy Manufacturing (CRC-CTM), Adelaide, South Australia, Australia
Department of Medicine, Faculty of Health and Medical Sciences, University of Adelaide, South Australia, Australia
Search for other papers by Patrick T Coates in
Google Scholar
PubMed
Radford T Kay TW Horowitz M Coates PT , et al . Islet cell transplantation in Australia: screening, remote transplantation, and incretin hormone secretion in insulin independent patients . Hormone and Metabolic Research
Search for other papers by Yusaku Mori in
Google Scholar
PubMed
Maebashi Hirosegawa Clinic, Maebashi, Gunma, Japan
Search for other papers by Hiroyuki Shimizu in
Google Scholar
PubMed
Search for other papers by Hideki Kushima in
Google Scholar
PubMed
Search for other papers by Tomomi Saito in
Google Scholar
PubMed
Search for other papers by Munenori Hiromura in
Google Scholar
PubMed
Search for other papers by Michishige Terasaki in
Google Scholar
PubMed
Search for other papers by Masakazu Koshibu in
Google Scholar
PubMed
Search for other papers by Hirokazu Ohtaki in
Google Scholar
PubMed
Search for other papers by Tsutomu Hirano in
Google Scholar
PubMed
Nohtomi K Kim-Kaneyama J Miyazaki A Hirano T . Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice . Diabetologia 2011 54 2649 – 2659 . ( https://doi.org/10.1007/s00125-011-2241-2 ) 10.1007/s00125
Search for other papers by Hugo R Ramos in
Google Scholar
PubMed
Department of Internal Medicine, Section of Metabolic Vascular Medicine, Division of Diabetes and Nutritional Sciences, Cardiovascular Endocrinology Laboratory, Faculty of Medicine, Hospital de Urgencias, National University of Córdoba, X5000 Córdoba, Argentina
Search for other papers by Andreas L Birkenfeld in
Google Scholar
PubMed
Search for other papers by Adolfo J de Bold in
Google Scholar
PubMed
(125) ; an observation that seems to depend on the amount of weight loss (126, 127) . Experimental data further suggests that the incretin glucagon like peptide 1 (GLP1) might be of relevance in the regulation of NP secretion. The GLP1 receptor agonist
Search for other papers by Paraskevi Kazakou in
Google Scholar
PubMed
Search for other papers by Stavroula A Paschou in
Google Scholar
PubMed
Search for other papers by Theodora Psaltopoulou in
Google Scholar
PubMed
Search for other papers by Maria Gavriatopoulou in
Google Scholar
PubMed
Search for other papers by Eleni Korompoki in
Google Scholar
PubMed
Search for other papers by Katerina Stefanaki in
Google Scholar
PubMed
Search for other papers by Fotini Kanouta in
Google Scholar
PubMed
Search for other papers by Georgia N Kassi in
Google Scholar
PubMed
Search for other papers by Meletios-Athanasios Dimopoulos in
Google Scholar
PubMed
Search for other papers by Asimina Mitrakou in
Google Scholar
PubMed
Practice 2020 162 108132 . ( https://doi.org/10.1016/j.diabres.2020.108132 ) 70 Drucker DJ The biology of incretin hormones . Cell Metabolism 2006 3 153 – 165 . ( https://doi.org/10.1016/j.cmet.2006.01.004 ) 71 Raj VS Mou H Smits SL Dekkers
Search for other papers by Mai Morsi in
Google Scholar
PubMed
Search for other papers by Torben Schulze in
Google Scholar
PubMed
Search for other papers by Eike Früh in
Google Scholar
PubMed
Search for other papers by Dennis Brüning in
Google Scholar
PubMed
Search for other papers by Uwe Panten in
Google Scholar
PubMed
Search for other papers by Ingo Rustenbeck in
Google Scholar
PubMed
no longer visible after culture of these islets ( 45 ). The authors hypothesized that the difference was due to the loss of an in vivo input like innervation or incretin hormones. The fact that the secretion pattern of the perfused mouse pancreas ( 46
Search for other papers by Bernardo Maia in
Google Scholar
PubMed
Neuroendocrinology Division – Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil
Endocrinology Division – Hospital Federal de Bonsucesso, Rio de Janeiro Brazil
Search for other papers by Leandro Kasuki in
Google Scholar
PubMed
Neuroendocrinology Division – Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil
Neuropatology and Molecular Genetics Laboratory – Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil
Search for other papers by Mônica R Gadelha in
Google Scholar
PubMed
mechanism of action of the drugs: PEGV improves insulin sensitivity by antagonizing GH action, while the hyperglycemic effect of PAS is related to inhibition of insulin production by β-pancreatic cells, in addition to suppression of incretins, regardless of
Search for other papers by Cleofas Marcial-Medina in
Google Scholar
PubMed
Search for other papers by Alejandra Ordoñez-Moreno in
Google Scholar
PubMed
Search for other papers by Christian Gonzalez-Reyes in
Google Scholar
PubMed
Search for other papers by Pedro Cortes-Reynosa in
Google Scholar
PubMed
Search for other papers by Eduardo Perez Salazar in
Google Scholar
PubMed
Experimental Metastasis 2010 27 505 – 515 . ( https://doi.org/10.1007/s10585-010-9340-1 ) 10.1007/s10585-010-9340-1 11 Hirasawa A Tsumaya K Awaji T Katsuma S Adachi T Yamada M Sugimoto Y Miyazaki S Tsujimoto G. Free fatty acids regulate gut incretin
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Pernille H Hellmann in
Google Scholar
PubMed
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Search for other papers by Jonatan I Bagger in
Google Scholar
PubMed
Search for other papers by Katrine R Carlander in
Google Scholar
PubMed
Search for other papers by Katrine B Hansen in
Google Scholar
PubMed
Search for other papers by Julie L Forman in
Google Scholar
PubMed
Search for other papers by Joachim Størling in
Google Scholar
PubMed
Search for other papers by Elizaveta Chabanova in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens Holst in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Search for other papers by Tina Vilsbøll in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
the incretin effect in healthy subjects . Journal of Clinical Endocrinology and Metabolism 2010 95 3309 – 3317 . ( https://doi.org/10.1210/jc.2010-0119 ) 9 Hansen KB Vilsbøll T Bagger JI Holst JJ & Knop FK . Increased postprandial GIP